Henlius Facts
  • 2010
    Founded in Shanghai
  • Stock Code
    2696.HK
  • First Launched
    Biosimilar in China
  • 30+
    Candidates in R&D
  • Global R&D Facilities
    Shanghai and California
Comprehensive Platform
News
关于
複宏漢霖
生物技術
上海复宏汉霖生物技术股份有限公司由复星医药与海外科学家团队于2010年2月合资组建,公司主要致力于符合全球标准的生物类似药及创新型抗体药物的研发和生产。
A Galaxy of Talents
A Galaxy of Talents
共谋发展

Henlius upholds the talent philosophy of “attracting people with visions, engaging people with rewards, cultivating people with challenges and assessing people with performance” and makes great efforts in attracting, empowering, retaining people and putting right people to right place.